Vaxcyte (PCVX) Earnings Date, Estimates & Call Transcripts $30.79 +0.02 (+0.06%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$30.78 0.00 (-0.02%) As of 08/29/2025 04:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vaxcyte Earnings Summary Vaxcyte announced Q2 2025 earnings on August 6, 2025, reporting an EPS of -$1.22, which missed the consensus estimate of -$1.12 by $0.10. With a trailing EPS of -$4.11, Vaxcyte's earnings are expected to decrease next year, from ($4.21) to ($4.49) per share. Upcoming Q3 Earnings DateNov. 4After Market ClosesEstimatedConsensus EPS (Aug. 6) -$1.12 Actual EPS (Aug. 6) -$1.22 Missed By -$0.10 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)PCVX Upcoming EarningsVaxcyte's next earnings date is estimated for Tuesday, November 4, 2025, based on past reporting schedules. Powered by Get Vaxcyte Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vaxcyte and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataPCVX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Vaxcyte Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$1.07-$1.07-$1.07Q2 20251-$1.18-$1.18-$1.18Q3 20251-$1.47-$1.47-$1.47Q4 20251-$1.50-$1.50-$1.50 Vaxcyte Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/4/2025(Estimated)--------8/6/2025Q2 2025-$1.12-$1.22 -$0.10-$1.22--5/14/2025Q1 2025-$1.02-$1.04 -$0.02-$1.04--2/25/2025Q4 2024-$1.16-$1.02+$0.14-$1.02--11/5/2024Q3 2024-$1.10-$0.83+$0.27-$0.83--8/6/2024Q2 2024-$1.14-$1.10+$0.04-$1.10--5/8/2024Q1 2024-$1.13-$0.85+$0.28-$0.85--2/27/2024Q4 2023-$0.89-$1.82 -$0.93-$1.82--11/6/2023Q3 2023-$0.84-$0.91 -$0.07-$0.91-- Vaxcyte Earnings - Frequently Asked Questions When is Vaxcyte's earnings date? Vaxcyte has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 4th, 2025 based off last year's report dates. Learn more on PCVX's earnings history. Did Vaxcyte beat their earnings estimates last quarter? In the previous quarter, Vaxcyte (NASDAQ:PCVX) missed the analysts' consensus estimate of ($1.12) by $0.10 with a reported earnings per share (EPS) of ($1.22). Learn more on analysts' earnings estimate vs. PCVX's actual earnings. How much profit does Vaxcyte generate each year? Vaxcyte (NASDAQ:PCVX) has a recorded net income of -$463.93 million. PCVX has generated -$4.11 earnings per share over the last four quarters. What is Vaxcyte's EPS forecast for next year? Vaxcyte's earnings are expected to decrease from ($4.21) per share to ($4.49) per share in the next year. More Earnings Resources from MarketBeat Related Companies GMAB Earnings Date VTRS Earnings Date RDY Earnings Date ASND Earnings Date QGEN Earnings Date MRNA Earnings Date VRNA Earnings Date BBIO Earnings Date ELAN Earnings Date ROIV Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B Contract This page (NASDAQ:PCVX) was last updated on 8/30/2025 by MarketBeat.com Staff From Our Partners“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxcyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxcyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PCVX Stock Alerts